Ensemble Ensemble
Menu
Home
  • SOLUTIONS
  • Method
    • A Systemic Approach
    • Theory of Constraints
    • Working with us
  • RESOURCES
    • Productivity Scorecard
    • Articles
    • Subscribe
    • Our book
  • Results
  • ABOUT
    • The Just Work Manifesto
    • Our Story
    • Location
Book a call
loader

Operations | Organisation | People | Process | Strategy

View all articles SUBSCRIBE TO NEWSLETTER to get articles and more

STAY CONNECTED AND SIGNUP TO RECEIVE INSIGHT updates

Subscribe

The 5-Step FOCUS – Uplift system performance

David Hodes, Founder

Once you’ve squeezed all the blood you can from a stone, it’s time to get more stones. In its essence, that’s what the uplift step is all about.

[ Listen to audio version, read by David Hodes]
 

This is Part 6 of our series on The 5-Step FOCUS:
Part 1 | Part 2 | Part 3 | Part 4 | Part 5 | Part 6 | Part 7

But, we must proceed with caution when pursuing this penultimate step of the 5-Step FOCUS, as it is an investment decision we’re about to make, and those decisions are highly consequential. My experience teaches me that investments are usually made too soon before the optimise and collaborate steps have had their chance to work their magic. Or, they are made in the wrong place and don’t deliver the step-change in the business’s long-term trajectory.

At a simple level, let’s look at a machine manufacturing widgets and the case where demand for widgets exceeds my capacity to produce them. I stop to consider if we have done everything we can to squeeze every last drop of production from my machine, its operators and its maintainers (note: if we’re using TOC practices, this doesn’t mean working people to the bone—merely optimising the work schedule). Some questions I might ask myself: Have I used quick changeover techniques to minimise downtime arising from product changes or maintenance events? Should I be running 24/7 shifts? Are there any operations performed by the machine that we could offload onto other machines? Could we contract a vendor to supply an intermediate product that will relieve the bottleneck capacity? Do we have the product mix right, meaning should we change the mix to something more profitable while simultaneously lessening the demand on the constraint?

Production goes beyond manufacturing

We could ask some of the same questions when it comes to managing our knowledge work. Replace the idea of a machine for a person or group for whom there is a high demand and a scarcity of supply, and you can repeat the cycle. Managing production is not a synonym for managing manufacturing. Whether in a factory or laboratory, an office or a studio, everyone produces a product or service that they hope their customers will value.

The exercise above should have you thinking about being careful about the assumptions you make when you’re ready for the uplift, and then being thorough as you consider the nature of that uplift. I have worked with a manufacturing organisation that had spent twenty-three million pounds on a new state-of-the-art machine, which was utterly unnecessary. I watched a mining house invest six hundred million dollars on an expansion of port capacity years ahead of when they needed it. I witnessed a global ERP rollout that had only a thirty-three per cent utilisation of the developers needed to design, build, and test the business solution.

But okay, there does come a time when you have to make an investment call. You’d hope that investment would align with your business strategy. And at this point comes a fascinating question. What business are you in? In Good to Great, Jim Collins told the story of Kimberly-Clark giving up their tissue mills to invest and focus on the consumer end of the market.

I recently set my mind to thinking about the implication of what such a choice might mean for a client of mine who runs an integrated mineral mine and processing plant—from pit to port. What, I wondered, if they were to give up the mining operation and focus on the processing alone? Could they sell the mine, generate great wads of cash from the sale and contract with the new owners to provide on-grade ore for the long term?

What would be the implication of being able to find alternate sources to their inputs? Better performance from the existing mine because it has to compete without the cover of being part of the same organisation? More opportunity to blend ores that could make the processing plant deliver higher volumes at lower costs? What would it mean if the processing plant focused on creating the intellectual property to run their processes at the bottom of the first quartile of the cost curve? In other words, what if, through leadership excellence in technology, process and people, they became the worldwide benchmark for processing their mineral?

No doubt they would be able to look at any other processing plant, anywhere in the world, using the same technology and know precisely how to get the maximum value from it. Could this mean that their best uplift step would be to embark on a strategy that included acquiring similar plants across the world whose operations could get a significant boost from the adoption of the newfound ways and means of their intellectual property?

Reformation or transformation?

Most uplift steps are reformations of the basic underlying business. You take a value chain, invest in its modernisation across people, process and technology and buy yourself a ticket to keep playing the game. In other words, reformation is changing the means, but not the ends. Transformation, a much-overused word, is changing both the means and the ends.

An uplift step that leads to the continuous improvement of a mineral processing plant, a software factory or an engineering consultancy is a reformation—selling the mine to become the world’s best at mineral processing is a transformation. A software factory or engineering consultancy transforms when it shifts its relationship from offering repeatable services—able to be replicated by any number of competitors—to partnering in defining their customer’s customer’s constraint and working symbiotically to exploit that innovative idea.

Whether your uplift step is reformative or transformational, you need to back it with an understanding of how it fits with your strategy to decrease the risk of failure. It also takes a significant amount of planning. When I was a student in London, Sir John Harvey-Jones was famous as the CEO of Britain’s then-largest corporation, ICI. He famously had this to say about the subject of planning:

Planning is an unnatural process; it is much more fun to do something. And the nicest thing about not planning is that failure comes as a complete surprise rather than being preceded by a period of worry and depression.

The uplift step’s planning function is related to the ideas contained in Elliott Jaques’s levels of work. The strategist’s mode of thinking, which correlates with their cognitive capacity, will govern the plan’s furthest horizon. You wouldn’t have a corporal make determinations about what is in the long-term interests of national security—that’s the job of the commander-in-chief.

You cannot say that you have completed your uplift planning if you haven’t tested the consequence of your decisions with where the constraint will move to. Furthermore, it is preferable to run scenario models of what you consider to be plausible and relevant to not only develop an optimal solution but also to mitigate the effects of the wishful thinking that you can come up with a single silver-bullet solution.

The deeper the horizon you are studying, the more complex and uncertain the terrain, the more adept you will need to be to accommodate the constraint. Supply may be compromised—what would you do? The market may collapse—what then? Your capacity to meet opportunistic demand is constrained—what action would you take? This scenario-based approach is not fanciful thinking when you consider the disruptions caused by, for example, the Corona pandemic. Who’s to say what the next disaster might be and what opportunities may present themselves as a consequence?

Once you know the compass setting for the uplift step, the work has barely begun. Implementing the uplift sits in the world of portfolios, programs and projects. It demands a thorough understanding of organisational change and how the big investment’s business benefits can be realised through its people. To quote Sir John Harvey-Jones again:

It is impossible to change organisations which do not accept the danger of their present way of doing things…organisations only change when the people in them change, and people will only change when they accept in their hearts that change must occur.

So, not only do we have to have the necessary execution capability to deliver the business benefits on our uplift investments—to scope, on time and on budget —but we also need to make the required investment in people to foster a culture with a high capacity for learning.

In conclusion, the uplift step is a function of how you define the system and its goal, where the current constraint is, how well you have optimised it, and what your ambition is for your enterprise’s future. As I said at the start, when you’ve squeezed all the blood you can from a stone—get more stones.

This is Part 6 of our series on The 5-Step FOCUS.

Part 1: Identifying the System
Part 2: Setting the Goal
Part 3: Find the constraint
Part 4: Optimise the Constraint
Part 5 : Collaborate Around the Constraint
Part 6 : Uplift System Performance
Part 7 : Start Again

____________________________
What’s next?

The change from standard thinking to Theory of Constraints (TOC) is both profound and exhilarating. To make it both fun and memorable, we use a business simulation we call The Right Stuff Workshop.

We’d love to run it with you. To learn more:

  • download the brochure (no email required)
  • schedule a call
    ____________________________

    Airplane wing

    [Background image: Francisco Torres on Unsplash]

     
     
     
     

    ____________________________

  • Culture
  • Operations
  • Process
  • Strategy

The healthcare professional: the hidden constraint in patient flow

Ensemble Administrator

Healthcare professionals are central to the patient’s progress from awareness of a therapy to successful long-term use. They identify risk, interpret evidence, diagnose conditions, discuss options, perform procedures, provide training and monitor outcomes.

Yet many medical device development programs treat healthcare professionals primarily as users to be trained or customers to be persuaded.

HCP-Centered Design takes a wider view. It examines the work healthcare professionals must perform, the system in which they perform it and the constraints that limit their ability to move suitable patients through the care pathway.

“If patient flow depends on a healthcare professional, that professional’s available capacity may determine how many patients ultimately receive the therapy.”

Healthcare professionals govern critical transitions

A medical device patient journey commonly depends on several healthcare professionals:

  • A primary care professional recognizes a problem or makes a referral.
  • A specialist assesses the patient and manages the disease pathway.
  • Diagnostic professionals generate and interpret evidence.
  • A managing physician supports authorization or reimbursement.
  • An interventional specialist confirms eligibility and performs a procedure.
  • Nurses, educators or allied health professionals help the patient adapt.
  • Follow-up teams monitor efficacy and coordinate adjustments.

Each professional governs a transition in the flow of patients.

If one transition lacks sufficient capacity, information or clarity, the whole pathway slows. More marketing, sales activity or production capacity will not compensate for a shortage of specialist time or a burdensome diagnostic process.

This is why HCP-Centered Design is not simply about making an interface easier to use. It is about enabling the system of care to perform.

The HCP works within a system

A healthcare professional’s work depends on information and actions supplied by others. They may rely on referrals, patient histories, pathology, imaging, electronic records, clinical guidelines and the availability of equipment or trained colleagues.

After reaching a decision, they may need to explain it, document it, arrange authorization, coordinate treatment and prepare the next person in the pathway.

A technically strong solution can still create difficulty if it:

  • Requires information that is hard to obtain
  • Interrupts established clinical workflows
  • Produces outputs that are difficult to interpret
  • Adds documentation without removing other work
  • Fails to connect with existing systems
  • Demands training that cannot be sustained
  • Transfers work or risk to another professional
  • Provides a result without clarifying the next action

The relevant design question is not merely, “Can the HCP use this product?”

It is, “Does this solution improve the HCP’s ability to complete important clinical work within the conditions in which care is actually delivered?”

Identify the real healthcare professional personas

“HCP” is not one persona.

A general practitioner, specialist, interventional physician, nurse, technician and clinical administrator encounter different stages of the pathway. Each has different responsibilities, authority, expertise and exposure to risk.

Even within a profession, context matters. An experienced specialist in a major hospital may approach the same task differently from a professional who encounters the condition infrequently or works without immediate specialist support.

Useful HCP personas distinguish factors that influence work:

  • Clinical responsibility and decision authority
  • Frequency of encountering the condition
  • Experience with the procedure or technology
  • Access to information and specialist support
  • Available time
  • Confidence in interpreting results
  • Responsibility for follow-up
  • Exposure to clinical, legal or financial risk

These personas clarify who performs each job and what support each person requires.

Map the HCP journey

The HCP journey often begins before the visible clinical procedure.

It may include receiving a referral, gathering information, forming an initial view, ordering investigations, interpreting results, deciding whether the patient is eligible, discussing treatment, obtaining authorization, preparing for the procedure, delivering care and arranging follow-up.

At each stage, ask:

  • What is the HCP trying to accomplish?
  • What information is required?
  • Where does the information come from?
  • What decision must be made?
  • What could cause delay or rework?
  • Who depends on this action?
  • What must happen before the patient can progress?

The resulting journey map should distinguish processing time from waiting time. A decision may require only minutes of specialist attention while patients wait weeks to access that attention.

This reveals the practical relationship between HCP capacity and patient flow.

Find the HCP constraint

The Theory of Constraints directs attention to the factor limiting the performance of the entire system.

In some pathways, the constraint may be the number of qualified interventional specialists. In others, it may be diagnostic capacity, physician confidence, authorization effort, operating room access or the time required to train patients.

The constraint may also be hidden inside the HCP’s working day.

A specialist supporting a therapy must still manage other clinical duties, administration, meetings, documentation and urgent cases. The question is not simply how many specialists exist. It is how much of their usable capacity is available for the activities upon which patient flow depends.

“The scarcest resource may not be the healthcare professional. It may be the few hours of focused capacity available for the critical work.”

Improvement away from this constraint can make performance worse. Sending more referrals to an already overloaded specialist increases the queue. Adding information may increase cognitive burden. Creating another approval may consume the capacity required to treat patients.

HCP-Centered Design seeks to protect and expand the capacity that governs flow.

Go to the clinical Gemba

Policies and procedures describe how clinical work should happen. Observation reveals how it actually happens.

Healthcare professionals routinely compensate for missing information, awkward interfaces and unreliable handovers. These workarounds may become so familiar that nobody reports them as problems.

Gemba research should examine:

  • How the HCP prepares
  • Which tools and information sources are used
  • What interrupts the work
  • Where the HCP waits or repeats activity
  • How uncertainty is communicated
  • What must be documented
  • How work passes to the next person
  • How the HCP recognizes that the job is complete

The purpose is not to judge the healthcare professional. It is to understand the system surrounding the work.

“A workaround is often evidence that the system has failed to support the person doing the work.”

Define the HCP’s job to be done

Healthcare professionals do not simply use devices. They use them to make progress in clinical work.

An HCP may need to identify risk, reach a confident diagnosis, select an intervention, perform a procedure safely, explain options, monitor progress or recognize deterioration.

A structured job map divides this work into eight stages:

  1. Define the intended clinical outcome.
  2. Locate the necessary information and resources.
  3. Prepare the patient, equipment and environment.
  4. Confirm readiness and choose between alternatives.
  5. Execute the clinical activity.
  6. Monitor its progress and results.
  7. Modify the approach when circumstances change.
  8. Conclude, document and prepare for subsequent care.

This wider view prevents the product team from concentrating exclusively on the procedure.

The greatest value may come from reducing preparation, improving decision confidence, clarifying an exception, simplifying documentation or improving the handover to follow-up care.

Convert experience into measurable outcomes

Comments such as “the interface is difficult” or “we need better information” indicate dissatisfaction, but do not provide sufficient direction for design.

They should be translated into measurable outcome statements, such as:

“Minimize the time required to identify which clinical information is missing before making a treatment decision.”

Or:

“Reduce the likelihood that a clinically significant change goes unrecognized between scheduled reviews.”

A broader population of healthcare professionals can then assess the importance of each outcome and their satisfaction with their current ability to achieve it.

Highly important and poorly satisfied outcomes provide a rational basis for prioritizing innovation.

“Adoption follows when a solution makes important clinical work safer, clearer or easier to complete.”

Apply FOCUS to HCP capacity

The five-step FOCUS process creates a practical improvement cycle.

Find the constraint. Determine which HCP activity or resource currently limits patient flow.

Optimise for it. Protect the constraint from avoidable work, missing information, interruptions and rework.

Collaborate around it. Align upstream and downstream teams so patients, information and resources arrive when required.

Uplift it. Add capacity, redesign responsibilities, improve technology or remove restrictive policies.

Start Again. Identify the new constraint once flow improves.

This approach allows the organization to distinguish activity from value. It also turns HCP engagement into an ongoing management discipline.

Connect HCP evidence with enterprise execution

HCP-Centered Design must connect clinical reality with patient needs, technology, regulation and business strategy.

A Value Management Office can help coordinate these perspectives across the product lifecycle. Its role is to ensure that projects, resources and stage-gate decisions remain connected to patient flow and business value.

The organization should be able to show:

  • Which HCP groups influence the pathway
  • What each group is trying to accomplish
  • How the work happens in practice
  • Which outcomes remain poorly served
  • Where HCP capacity constrains patient flow
  • How the proposed solution changes the wider care system
  • How improvement will be measured

The goal is not simply a device that healthcare professionals can operate. It is a solution they can confidently incorporate into care and a delivery system capable of getting that solution to more patients.


What’s next?

Use the HCP-Centered Design assessment to determine how well your organization understands clinical work, HCP capacity and the constraints governing patient flow.

The resulting evidence should guide product design, process improvement and investment toward better products, delivered faster, with more lives changed for good.

READ MORE

  • Operations
  • People
  • Process
  • Strategy

Patient flow: the missing system in Patient Centered Design

Ensemble Administrator

Medical device companies devote enormous skill and investment to developing safe, effective products. Yet a technically successful device changes no lives while suitable patients remain unable to reach it.

Between a patient becoming aware of a therapy and receiving its intended benefit lies a pathway of referrals, consultations, diagnostics, approvals, procedures, training and follow-up. Every step consumes time. Between the steps, patients wait. At some points, they become confused, discouraged, ineligible or lost to the process.

Patient Centered Design must therefore address more than the design of the device. It must improve the performance of the entire system through which patients reach, receive and live successfully with the solution.

“A life-changing therapy changes no lives while patients remain trapped in the pathway leading to it.”

The patient journey is a flow system

A typical medical device journey may include:

  1. The patient becomes aware of a possible therapy.
  2. A primary care professional or specialist assesses the patient.
  3. Diagnostic work determines whether the therapy is appropriate.
  4. The patient secures authorization or reimbursement.
  5. An interventional specialist confirms and plans the procedure.
  6. The patient receives the device or therapy.
  7. The patient learns how to live with the solution.
  8. Follow-up identifies any necessary adjustments.
  9. Periodic reviews monitor longer-term efficacy.

Companies often manage these stages as separate functions. Marketing works on awareness. Medical affairs supports clinicians. Market access addresses reimbursement. Sales works with specialists. Clinical teams gather evidence. Training teams support adoption.

The patient, however, experiences one journey.

From the patient’s perspective, a delay between two organizational functions remains a delay. A repeated test remains repeated work. An unclear handover creates uncertainty regardless of which department owns it.

Patient Centered Design begins when the organization sees and manages this journey as a connected system.

Processing time tells only part of the story

Every step contains some necessary processing time. A consultation takes time. A diagnostic test takes time. An authorization must be assessed. A procedure must be performed.

The patient’s total lead time, however, also includes the waiting between these activities.

A consultation may take 30 minutes, but the patient could wait six weeks for it. A diagnostic test may take an hour, followed by another delay before a specialist reviews the result. Prior authorization may require little actual work while adding weeks to the pathway.

This distinction matters because organizations often improve processing time while leaving the larger queues untouched. Saving five minutes during an appointment produces little benefit if the patient waits months to reach it.

Patient Centered Design therefore asks:

  • How long does each activity take?
  • How long do patients wait between activities?
  • How many suitable patients enter each stage?
  • How many progress to the next stage?
  • Where and why do patients leave the pathway?
  • How much total time passes before the patient receives the solution?

The answers reveal the true performance of the patient system.

Find the constraint

Theory of Constraints teaches that the performance of any system is limited by a constraint. Improving a part of the system that is not constraining flow may create more activity without increasing results.

If diagnostic capacity is the constraint, generating more awareness may simply produce a longer queue for diagnosis. If specialist capacity is the constraint, accelerating authorization may move patients more quickly into another wait. If training after first use is inadequate, increasing procedures may produce poor experiences and avoidable follow-up demand.

“More activity at a non-constraint creates work in process. More capability at the constraint improves the system.”

The constraint is not always a physical resource. It may be a policy, an eligibility rule, missing evidence, a fragmented handover, an information delay or the cognitive burden placed on the patient.

The most important question is therefore not, “How do we improve every step?”

It is, “What currently limits the flow of suitable patients to successful use of the therapy?”

Understand why patients remain in or leave the flow

Numbers show where patients are lost. Patient research helps explain why.

Two patients with the same diagnosis may respond very differently. One may actively seek new treatment options. Another may delay action until symptoms become severe. A third may want help but lack confidence in navigating the healthcare system.

Meaningful patient segmentation considers characteristics that influence behavior:

  • The importance the person gives their health
  • Their confidence in dealing with healthcare professionals
  • Whether they act independently or need encouragement
  • Their comfort with technology
  • The pressures of work, family and daily life
  • Their ability to understand and act on clinical information
  • Their willingness and ability to pay
  • The outcomes they most want to achieve

These differences affect whether patients enter the pathway, remain engaged and successfully adopt the solution.

Go to the patient’s Gemba

The Gemba is the place where work actually happens. For patients, this includes the home, clinic, hospital and all the places where they manage their condition between formal encounters.

Interviews alone may miss important evidence. People normalize inconvenience, forget workarounds and simplify their past decisions. Observation allows the development team to see what patients actually do.

Good research combines three activities.

Observe. Watch how patients obtain information, prepare, use the solution and respond when something goes wrong.

Immerse. Understand the physical, emotional and practical conditions surrounding the experience.

Engage. Ask open questions that allow patients to describe their goals, fears and frustrations in their own language.

The purpose is to discover the patient’s reality before asking them to evaluate the organization’s preferred answer.

Understand the patient’s job to be done

Patients rarely want a medical device for its own sake. They want the progress it may enable.

They may want to recognize deterioration earlier, preserve independence, reduce pain, avoid repeated visits, return to work or prevent a disease from controlling daily life.

A useful job map examines eight recurring stages:

  1. Define what must be achieved.
  2. Locate the required information and resources.
  3. Prepare for the activity.
  4. Confirm readiness and choose between alternatives.
  5. Execute the activity.
  6. Monitor whether it is working.
  7. Modify the approach when circumstances change.
  8. Conclude or prepare for what follows.

This reveals opportunities beyond the immediate use of the device. The most valuable improvement may involve helping patients prepare, confirm readiness, recognize an exception or understand what happens next.

Turn patient experiences into evidence

Stories create understanding, but investment decisions require structured evidence.

Patient observations and comments should be converted into outcome statements that identify:

  • The desired direction of improvement
  • A measure of success
  • The object being controlled
  • The circumstances in which it matters

For example:

“Minimize the time required to recognize that my condition has changed sufficiently to require clinical help.”

Patients can then assess the importance of each outcome and their satisfaction with their current ability to achieve it.

Highly important and poorly satisfied outcomes represent genuine opportunities. This prevents teams from prioritizing attractive features that do not materially improve the patient’s life or progress through the pathway.

“Innovation becomes valuable when it improves an outcome that matters and remains poorly served.”

Apply the five-step FOCUS process

The Patient Centered Design pathway can be improved through a repeating discipline:

Find the constraint. Identify what currently limits patient flow or successful use.

Optimise for it. Make the best possible use of existing constraint capacity.

Collaborate around it. Align functions and partners so their actions support the constraint.

Uplift it. Add capability, remove restrictive policies or redesign the pathway.

Start Again. Once the constraint moves, identify and address the next limiting factor.

This prevents improvement from becoming a collection of disconnected initiatives. It directs scarce resources toward the factor that most strongly governs the result.

Patient Centered Design is an operating system

Patient insight should influence more than early product design. It should shape clinical evidence, regulatory strategy, reimbursement, manufacturing, education, market development and post-market support.

The organization should be able to show:

  • Which patients it intends to serve
  • What those patients are trying to accomplish
  • How the complete patient pathway operates
  • Where patients wait or leave the flow
  • Which outcomes remain poorly served
  • What currently constrains successful patient access
  • How the proposed solution improves the whole system

The goal is not simply to place the patient at the center of a diagram. It is to organize the enterprise around delivering better products faster, so that more lives can be changed for good.


What’s next?

Use the Patient Centered Design assessment to determine how well your organization understands its patient journeys, priority outcomes and constraints to patient flow.

The result should be more than another collection of patient opinions. It should provide evidence that directs strategy, investment and execution toward the changes that matter most.

READ MORE

More than just work

Discover better ways to do better work.

Fresh insights, every Friday

We alternate our own actionable articles with three relevant links from other authorities.

We’ll only use your email address for this newsletter. No sales calls

    Subscribe to 'Perspectives'

    [recaptcha id:cf7note]

    More Than Just Work
    Weekly productivity insights

    Subscribe
    • EnsembleConsultingGroup
    • Share Page
    • +61 2 9387 3955
    • info@EnsembleConsultingGroup.com

    Site proudly designed by Brand Fibre

    What is to get in touch with you?



    More than just work

    Discover better ways to do better work.

    Fresh insights, every Friday

    We alternate our own actionable articles with three relevant links from other authorities.


    We’ll only use your email address for this newsletter. No sales calls

    white_arrow white_bidirection_arrow arrow-right-green arrow-right-orange arrow-right arrow-left blue_arrow blue_round_arrow tick

    Want us to get in touch with you?

     
    Thank you for your interest. We will call you back.